The effects of short-term and long-term testosterone supplementation on blood viscosity and erythrocyte deformability in healthy adult mice.
暂无分享,去创建一个
Nicolae L. Sandor | M. Gassmann | S. Bhasin | Ravi Jasuja | K. Pencina | J. Vogel | M. Montano | S. Basaria | Eric S. Bachman | Michelle Li | Wen Guo | Carlo Serra | Liming Peng
[1] Ying Li,et al. Increased whole blood viscosity is associated with silent cerebral infarction. , 2015, Clinical hemorheology and microcirculation.
[2] M. Lagerquist,et al. The effect of estrogen on bone requires ERα in nonhematopoietic cells but is enhanced by ERα in hematopoietic cells. , 2014, American journal of physiology. Endocrinology and metabolism.
[3] T. Travison,et al. Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.
[4] S. Greenland,et al. Increased Risk of Non-Fatal Myocardial Infarction Following Testosterone Therapy Prescription in Men , 2014, PloS one.
[5] G. Hankey,et al. In older men an optimal plasma testosterone is associated with reduced all-cause mortality and higher dihydrotestosterone with reduced ischemic heart disease mortality, while estradiol levels do not predict mortality. , 2014, The Journal of clinical endocrinology and metabolism.
[6] G. Grunwald,et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. , 2013, JAMA.
[7] O. Baskurt,et al. Blood rheology and aging , 2013, Journal of geriatric cardiology : JGC.
[8] O. Rouaud,et al. A J-shaped association between plasma testosterone and risk of ischemic arterial event in elderly men: the French 3C cohort study. , 2013, Maturitas.
[9] D. Delev,et al. Effect of Testosterone Propionate on Erythropoiesis after Experimental Orchiectomy , 2013, Folia medica.
[10] D. Moon,et al. Effect of testosterone undecanoate on hematological profiles, blood lipid and viscosity and plasma testosterone level in castrated rabbits. , 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.
[11] T. Travison,et al. Testosterone administration inhibits hepcidin transcription and is associated with increased iron incorporation into red blood cells , 2013, Aging cell.
[12] Z. Kamenov,et al. Testosterone replacement therapy improves erythrocyte membrane lipid composition in hypogonadal men , 2012, The aging male : the official journal of the International Society for the Study of the Aging Male.
[13] R. Rosenson,et al. Importance of Blood Rheology in the Pathophysiology of Atherothrombosis , 2012, Cardiovascular Drugs and Therapy.
[14] T. Travison,et al. Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis. , 2010, The Journal of clinical endocrinology and metabolism.
[15] A. Jette,et al. Adverse events associated with testosterone administration. , 2010, The New England journal of medicine.
[16] R. Rosenson,et al. Cardiovascular Risks of Anemia Correction with Erythrocyte Stimulating Agents: Should Blood Viscosity Be Monitored for Risk Assessment? , 2010, Cardiovascular Drugs and Therapy.
[17] Ping Song,et al. AMPKα1 Deletion Shortens Erythrocyte Life Span in Mice , 2010, The Journal of Biological Chemistry.
[18] Broulík Pd. The effect of castration and androgen treatment on glomerular volume in mice. , 2009 .
[19] L. Maffei,et al. Testosterone action on erythropoiesis does not require its aromatization to estrogen: Insights from the testosterone and estrogen treatment of two aromatase-deficient men , 2009, The Journal of Steroid Biochemistry and Molecular Biology.
[20] R. Vasan,et al. The impact of assay quality and reference ranges on clinical decision making in the diagnosis of androgen disorders , 2008, Steroids.
[21] A. Dobs,et al. Effect of methyl testosterone administration on plasma viscosity in postmenopausal women , 2002, Clinical endocrinology.
[22] R. Francis,et al. Androgen supplementation in eugonadal men with osteoporosis-effects of 6 months of treatment on bone mineral density and cardiovascular risk factors. , 1996, Bone.
[23] G. Gorodeski. Impact of the menopause on the epidemiology and risk factors of coronary artery heart disease in women , 1994, Experimental Gerontology.
[24] G. Bartosz,et al. The effect of donor age on the packing susceptibility of erythrocytes , 1988, Mechanisms of Ageing and Development.
[25] G. Biasi,et al. Arterial and venous blood viscosity in ischemic lower limbs in patients affected by peripheral obliterative arterial disease. , 1979, The Journal of cardiovascular surgery.
[26] J. Naets,et al. THE MECHANISM OF ACTION OF ANDROGENS ON ERYTHROPOIESIS * , 1965, Annals of the New York Academy of Sciences.
[27] M. Gassmann,et al. Scientific Heading: RED CELLS Transgenic mice overexpressing erythropoietin adapt to excessive erythrocytosis by regulating blood viscosity , 2003 .
[28] H S Borovetz,et al. Red blood cell aging and risk of cardiovascular diseases. , 1998, Clinical hemorheology and microcirculation.
[29] P. Broulik,et al. The effect of castration and androgen treatment on glomerular volume in mice. , 1983, Experimental and clinical endocrinology.
[30] P. L. la Celle,et al. Blood viscosity and thrombosis: clinical considerations. , 1982, Progress in hemostasis and thrombosis.
[31] Lacelle Pl,et al. Blood viscosity and thrombosis: clinical considerations. , 1982 .